Literature DB >> 15607698

HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.

James C Barton1, Howard W Wiener, Ronald T Acton, Rodney C-P Go.   

Abstract

Before the discovery of HFE, reports suggested that hemochromatosis patients with the ancestral haplotype (or some element thereof) have more severe iron overload than those without the haplotype. We performed univariate and multivariate analyses of the relationships of human leukocyte antigen (HLA)-A*03 and HLA haplotype A*03-B*07 to iron measures (serum iron concentration, transferrin saturation, and serum ferritin concentration at diagnosis and units of phlebotomy to achieve iron depletion) in hemochromatosis probands homozygous for HFE C282Y diagnosed in medical care. Iron overload was defined by demonstration of hepatic iron index of > or =1.9 or removal of > or =2.0 g Fe by therapeutic phlebotomy. We tabulated the phenotype frequencies of HLA-A*03 and the frequencies of common HLA haplotypes A*01-B*08, A*02-B*44, A*03-B*07, and A*03-B*14 in three groups of white adults: (1) 141 hemochromatosis probands with C282Y homozygosity; (2) 195 index cases with IgG subclass deficiency (IgGSD) or common variable immunodeficiency (CVID), disorders typically linked to Ch6p, and (3) 750 control subjects. Among probands, 86 men and 42 women had iron overload. Frequencies of HLA-A and -B alleles in probands did not depart significantly from Hardy-Weinberg equilibrium. The phenotype frequency of A*03 did not differ significantly between men and women in the each of the respective three groups. The frequency of haplotype A*03-B*07 was greater in men than women with hemochromatosis (0.3081 vs. 0.1455; P = 0.0019). The frequency of A*03-B*014 was significantly greater in women than men with hemochromatosis (0.1182 vs. 0.0407, respectively; P = 0.0134). Mean values of most iron measures were not affected by numbers of copies of A*03 or by presence of A*03-B*07 in either men or women in univariate analysis. ANOVA models of sex, age at diagnosis, and all HLA alleles and haplotypes in probands were used to determine effects of these variables on iron measures. ANOVA models revealed that (1) there were no significant predictors for serum iron concentration; (2) B*14 is associated with higher transferrin saturation in women and lower transferrin saturation in men; (3) A*01-B*08 is associated with a trend of higher serum ferritin levels; and (4) A*03-B*14 is associated with exaggeration of the age-associated upward trend in units of phlebotomy to achieve iron depletion. In hemochromatosis probands with HFE C282Y homozygosity, we conclude that (1) disparate frequencies of HLA haplotypes A*03-B*07 and A*03-B*14 occur in men and women and (2) HLA-A*03 and HLA-A*03-B*07 are not independent variables associated with iron overload severity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607698     DOI: 10.1016/j.bcmd.2004.08.022

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  9 in total

1.  Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Authors:  Charles A Rivers; James C Barton; Victor R Gordeuk; Ronald T Acton; Mark R Speechley; Beverly M Snively; Catherine Leiendecker-Foster; Richard D Press; Paul C Adams; Gordon D McLaren; Fitzroy W Dawkins; Christine E McLaren; David M Reboussin
Journal:  Blood Cells Mol Dis       Date:  2007-02-05       Impact factor: 3.039

2.  Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients.

Authors:  C A McCune; D Ravine; K Carter; H A Jackson; D Hutton; J Hedderich; M Krawczak; M Worwood
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

3.  Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS study.

Authors:  James C Barton; Catherine Leiendecker-Foster; David M Reboussin; Paul C Adams; Ronald T Acton; John H Eckfeldt
Journal:  Thyroid       Date:  2008-08       Impact factor: 6.568

4.  A study of 82 extended HLA haplotypes in HFE-C282Y homozygous hemochromatosis subjects: relationship to the genetic control of CD8+ T-lymphocyte numbers and severity of iron overload.

Authors:  Eugénia Cruz; Jorge Vieira; Susana Almeida; Rosa Lacerda; Andrea Gartner; Carla S Cardoso; Helena Alves; Graça Porto
Journal:  BMC Med Genet       Date:  2006-03-01       Impact factor: 2.103

5.  Total blood lymphocyte counts in hemochromatosis probands with HFE C282Y homozygosity: relationship to severity of iron overload and HLA-A and -B alleles and haplotypes.

Authors:  James C Barton; Ronald T Acton; Howard W Wiener; Rodney Cp Go
Journal:  BMC Blood Disord       Date:  2005-07-25

6.  Ancestral association between HLA and HFE H63D and C282Y gene mutations from northwest Colombia.

Authors:  Libia M Rodriguez; Mabel C Giraldo; Laura I Velasquez; Cristiam M Alvarez; Luis F Garcia; Marlene Jimenez-Del-Rio; Carlos Velez-Pardo
Journal:  Genet Mol Biol       Date:  2014-03-17       Impact factor: 1.771

Review 7.  Pathophysiological consequences and benefits of HFE mutations: 20 years of research.

Authors:  Ina Hollerer; André Bachmann; Martina U Muckenthaler
Journal:  Haematologica       Date:  2017-03-09       Impact factor: 9.941

8.  Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.

Authors:  James C Barton; Ellen H Barton; Ronald T Acton
Journal:  BMC Med Genet       Date:  2006-03-13       Impact factor: 2.103

9.  Effects of highly conserved major histocompatibility complex (MHC) extended haplotypes on iron and low CD8+ T lymphocyte phenotypes in HFE C282Y homozygous hemochromatosis patients from three geographically distant areas.

Authors:  Mónica Costa; Eugénia Cruz; James C Barton; Ketil Thorstensen; Sandra Morais; Berta M da Silva; Jorge P Pinto; Cristina P Vieira; Jorge Vieira; Ronald T Acton; Graça Porto
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.